Societal CDMO to be bought by another manufacturer, CoreRx, for $1.10 a share
Small molecule manufacturer Societal CDMO will be acquired by drug manufacturer CoreRx for $1.10 a share, with Societal having recently undergone “strategic realignment” and downsizing of its early-stage services.
As of Nov. 1, Societal has 104.8 million outstanding shares. According to William Blair, the deal brings the CDMO’s value to $130 million. Its stock $SCTL skyrocketed 130% before the market opened on Wednesday. It has a $48.2 million market cap.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.